Literature DB >> 12618252

The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.

A Novák1, C de la Loge, L Abetz, E A van der Meulen.   

Abstract

The acceptability of the combined contraceptive vaginal ring, NuvaRing, was assessed during two trials conducted in North America and Europe. Women completed a questionnaire about the ring's clarity of instructions, ease of use, sexual comfort, cycle-related characteristics and satisfaction after 3, 6 and 13 cycles of use. A total of 1,950 women (82% of those recruited) completed a questionnaire at cycle 3. At baseline, 66% of participants preferred oral contraceptives, but after three cycles of ring use 81% preferred the ring. On study completion, 97% agreed that the instructions for use were clear; 85% of women and 71% of their partners never/rarely felt the ring during intercourse and 94% of partners never/rarely minded that the woman was using the ring. Overall acceptance was high, 96% were satisfied with the ring and 97% would recommend the ring. Similar responses were seen for women who prematurely discontinued from the studies, except that slightly fewer women were satisfied (60%) and would recommend the ring (75%). Reasons for liking the ring included 'not having to remember anything' (45%) and 'ease of use' (27%). In conclusion, there is a high level of user and partner acceptability for the contraceptive ring.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618252     DOI: 10.1016/s0010-7824(02)00514-0

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  40 in total

1.  Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing.

Authors:  Annoesjka Novák; Christine de la Loge; Linda Abetz
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials.

Authors:  Peter Dogterom; Michiel W van den Heuvel; Torben Thomsen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  The ORTHO BC-SAT--a satisfaction questionnaire for women using hormonal contraceptives.

Authors:  H H Colwell; S D Mathias; T A Cimms; M Rothman; A J Friedman; D L Patrick
Journal:  Qual Life Res       Date:  2006-09-21       Impact factor: 4.147

4.  Matched-pairs analysis of ovarian suppression during oral vs. vaginal hormonal contraceptive use.

Authors:  Kelsey A Petrie; Anu H Torgal; Carolyn L Westhoff
Journal:  Contraception       Date:  2011-06-16       Impact factor: 3.375

5.  Adolescent experiences with the vaginal ring.

Authors:  Laura B Epstein; Karen Sokal-Gutierrez; Susan L Ivey; Tina Raine; Colette Auerswald
Journal:  J Adolesc Health       Date:  2008-03-10       Impact factor: 5.012

Review 6.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

7.  Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2011-06       Impact factor: 4.617

8.  Multicenter Study of Contraceptive Vaginal Ring (NuvaRing(®)) in Normal Daily Practice in Indian Women.

Authors:  Suchitra N Pandit; Anahita R Chauhan; Manjula Anagani; Sanjeeva Reddy; Ashish Birla; Subrat K Ray
Journal:  J Obstet Gynaecol India       Date:  2014-05-15

9.  Contraception for adolescents with lupus.

Authors:  Melissa S Tesher; Amy Whitaker; Melissa Gilliam; Linda Wagner-Weiner; Karen B Onel
Journal:  Pediatr Rheumatol Online J       Date:  2010-03-31       Impact factor: 3.054

10.  Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing).

Authors:  Devorah R Wieder; Lynn Pattimakiel
Journal:  Int J Womens Health       Date:  2010-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.